Exemestane (Aromasine) + Tamoxifen - Breast Neo-Adjuvant

Clinical trial NCT00919399 · COMPLETED

Trial details

NCT number: NCT00919399
Sponsor: Institut Claudius Regaud
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2002-01-01
Primary completion: 2006-06-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.